At Legency Remedies Pvt. Ltd., research and development forms the foundation of our leadership as a WHO-GMP certified respule manufacturer in India. Our advanced R&D division focuses on respiratory drug delivery systems, preservative-free formulations, and innovative packaging technologies to ensure safety, stability, and superior therapeutic outcomes across India and 50+ export markets.
Our Commitment to Compliance and Quality
As a leading respule pharmaceutical company, we formulate our range of medicines using superior quality active pharmaceutical ingredients and excipients sourced from certified global suppliers. Starting from the procurement of raw materials to the final packaging of consignments, our processes are subjected to stringent quality checks at our WHO GMP certified facility in Baddi, Himachal Pradesh. We are assisted by a dedicated team of quality controllers who conduct every test as per international GMP standards. Our quality assurance department is completely functional with a zero-tolerance policy, ensuring every batch of WHO GMP certified respules, rotacaps, and CE certified saline pods meets the highest pharmaceutical standards. Our R&D team works closely with our quality assurance division to develop formulations that are not only therapeutically effective but also stable, preservative-free, and patient-friendly. This collaboration has positioned us as a trusted third party respule manufacturer for leading pharma brands across India.
Driving Innovation in Respiratory Drug Deliver
Our injectable and inhalation portfolio is among the fastest-growing segments of medicine owing to the simplicity in treatment and instantaneous therapeutic results. As top respule manufacturers in Himachal Pradesh, we specialize in developing preservative-free, single-dose respules using advanced Blow-Fill-Seal (BF-S) technology that ensures sterility and dosage accuracy. Our R&D capabilities extend across multiple respiratory delivery platforms:
Respules & Nebulization Solutions: We have developed 18+ preservative-free respule formulations including budesonide, levosalbutamol, ipratropium, and combination therapies. Each formulation undergoes extensive stability testing and clinical evaluation to ensure efficacy and safety. Our respules in third party manufacturer programs allow pharmaceutical companies to offer proven, WHO GMP certified respiratory solutions under their own brands.
Rotacaps & DPI Technology: As a leading rota caps third party manufacturing company, we develop dry powder inhalation formulations compatible with our proprietary RiteHaler two-pin device, recognized as a top DPI device for rotacaps in India. Our rotacaps in third party manufacturing portfolio includes 15+ formulations across bronchodilators, corticosteroids, and combination therapies designed for optimal lung deposition and patient compliance.
CE Certified Medical Devices:
Our R&D division has successfully developed
CE certified saline pods
and sodium chloride irrigation solutions that meet European regulatory standards.
These export-ready products demonstrate our commitment to innovation and global quality benchmarks.
We also provide customized packaging solutions for our medicines to gain utmost client satisfaction and enhance product differentiation for our
respules PCD pharma franchise and rotacaps PCD pharma franchise partners.
Our vision is to become a quality-driven company making the Indian pharmaceutical industry self-reliant in specialized respiratory product lines with exports as a major thrust.
Advanced Research for Next-Gen Pharma Product
Our research and development facility is equipped with modern laboratories and advanced analytical instruments that enable comprehensive formulation development, stability studies, and quality testing. As one of the leading pharma companies in India focused on respiratory care, we continuously invest in R&D infrastructure to stay ahead of evolving market demands.
- Formulation development for respules, rotacaps, inhalers, and nasal sprays
- Stability studies as per ICH guidelines for tropical and global markets
- Bioequivalence and dissolution testing for DPI formulations
- Device compatibility testing for rotacaps and inhaler devices
- Packaging innovation for preservative-free, single-dose delivery
- Regulatory documentation support for third party manufacturing clients
- Custom formulation development for PCD pharma franchise partners
Our R&D team collaborates with leading pulmonologists, formulators, and regulatory experts to ensure our products meet the evolving needs of respiratory therapy. This integrated approach has enabled us to establish ourselves as a preferred partner for inhaler in PCD pharma franchise and respules in PCD pharma franchise opportunities across India.
Partner with a Research-Driven Respule Manufacturing Company
Whether you're looking for WHO GMP certified respules for third party manufacturing, need a reliable rota caps third party manufacturing company for your DPI range, or want to launch an inhaler PCD pharma franchise with proven formulations—Legency Remedies offers the R&D expertise, manufacturing excellence, and regulatory support you need.
Explore our complete product portfolio or discuss custom formulation development with our team.